Brief: Neuropace Receives IDE Approval To Initiate NAUTILUS Pivotal Study Of Its RNS System
10/11/2021 21:49
Nov 10 (Reuters) - Neuropace Inc NPCE.O :
* NEUROPACE RECEIVES IDE APPROVAL TO INITIATE NAUTILUS
PIVOTAL
STUDY OF ITS RNS SYSTEM FOR IDIOPATHIC GENERALIZED EPILEPSY
Source text for Eikon: ID:nGNX3DjV8p
Further company coverage: NPCE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuroPace
See all newsMedTech growth concerns likely to overshadow Q3 results, Leerink says
NeuroPace, Inc. reports results for the quarter ended June 30 - Earnings Summary
NeuroPace Q2 revenue slightly beats estimates
Brief: NeuroPace, Inc. Q2 EPS USD -0.18
NeuroPace, Inc. expected to post a loss of 21 cents a share - Earnings Preview